TY - JOUR
T1 - Array-CGH analysis and clinical description of 2q37.3 de novo subtelomeric deletion
AU - Kitsiou-Tzeli, Sofia
AU - Sismani, Carolina
AU - Ioannides, Marios
AU - Bashiardes, Stavros
AU - Ketoni, Andria
AU - Touliatou, Vassiliki
AU - Kolialexi, Aggeliki
AU - Mavrou, Ariadni
AU - Kanavakis, Emanuel
AU - Patsalis, Philippos C.
PY - 2007/1
Y1 - 2007/1
N2 - We report on a 13-year-old girl with normal karyotype and a de novo cryptic terminal deletion of chromosome 2q, detected by subtelomeric FISH analysis. Further investigation with array-CGH analysis using the 1 Mb resolution Spectral Chip 2600 (Spectral Genomics) confirmed the deletion and also showed a deletion of four additional clones. No other abnormalities were detected by array-CGH. FISH studies using 8 BAC-probes were performed for fine mapping of the deletion and confirmed the array results. FISH analysis showed that the deletion breakpoint lies between clones RP11-84G18 and RP11-83N2 (physical distance between clones 0.36 Mb) and extends to the telomere. The size of the deletion was estimated to be about 6.4-6.7 Mb. Clinical findings include: developmental delay, severe behavioural disturbances, growth-pubertal retardation, congenital conductive mild hearing loss, growth hormone deficiency, compensate hypothyroidism, dysmorphic facial features, excessive joint hypermobility, brachymetaphalangy, abnormal dermatoglyphics and a history of neonatal laryngomalacia, hypotonia and umbilical hernia. The phenotype of our patient is in keeping with those of the literature, with the exception of cardiovascular, urogenital, neurological anomalies and eczema, which were not observed. The report of the clinical and molecular presentation of similar cases will allow accurate phenotype-genotype correlation and proper genetic counseling of the family.
AB - We report on a 13-year-old girl with normal karyotype and a de novo cryptic terminal deletion of chromosome 2q, detected by subtelomeric FISH analysis. Further investigation with array-CGH analysis using the 1 Mb resolution Spectral Chip 2600 (Spectral Genomics) confirmed the deletion and also showed a deletion of four additional clones. No other abnormalities were detected by array-CGH. FISH studies using 8 BAC-probes were performed for fine mapping of the deletion and confirmed the array results. FISH analysis showed that the deletion breakpoint lies between clones RP11-84G18 and RP11-83N2 (physical distance between clones 0.36 Mb) and extends to the telomere. The size of the deletion was estimated to be about 6.4-6.7 Mb. Clinical findings include: developmental delay, severe behavioural disturbances, growth-pubertal retardation, congenital conductive mild hearing loss, growth hormone deficiency, compensate hypothyroidism, dysmorphic facial features, excessive joint hypermobility, brachymetaphalangy, abnormal dermatoglyphics and a history of neonatal laryngomalacia, hypotonia and umbilical hernia. The phenotype of our patient is in keeping with those of the literature, with the exception of cardiovascular, urogenital, neurological anomalies and eczema, which were not observed. The report of the clinical and molecular presentation of similar cases will allow accurate phenotype-genotype correlation and proper genetic counseling of the family.
KW - 2q
KW - Array-CGH
KW - Deletion
KW - FISH
KW - Mental retardation
KW - Phenotype-genotype correlation
KW - Subtelomeric
UR - https://www.scopus.com/pages/publications/33846263394
U2 - 10.1016/j.ejmg.2006.09.004
DO - 10.1016/j.ejmg.2006.09.004
M3 - Article
C2 - 17194633
AN - SCOPUS:33846263394
SN - 1769-7212
VL - 50
SP - 73
EP - 78
JO - European Journal of Medical Genetics
JF - European Journal of Medical Genetics
IS - 1
ER -